-
BEYOND-9 hemophilia B gene therapy clinical trial launched in four Canadian study sites
Montreal, February 5, 2026 – Four Canadian bleeding disorder treatment centres are participating in the Phase 1 clinical trial of Regeneron’s CRISPR/Cas9-based targeted gene insertion therapy for hemophilia B....
New podcasts!
Coproduced by the Canadian Hemophilia Society and the Irish Haemophilia Society, two new podcasts discussing hemophilia gene therapy have been released! These are part of our second series on...
Recruitment at the Board of Directors
You would like to have a significant impact in the Canadian bleeding disorder community? Here’s your chance, the CHS Board of Directors is recruiting. Please CLICK HERE for full details...
Time to apply!
It is time to apply for the James Kreppner Memorial Scholarship and Bursary Program. CLICK HERE for all the details and to apply.
